BusinessMirror

On Covid-19 vaccines

- Sonny M. Angara

ACcording to the February 24 Bloomberg data, some 213 million Covid-19 vaccine doses have already been administer­ed across 95 countries. And with an average inoculatio­n rate of 6.1 million a day, it was estimated that it will take 5.1 years before global herd immunity—where at least 75 percent of the world’s population is vaccinated—will be achieved.

Attaining this herd immunity to finally end the pandemic entails surmountin­g the greatest logistical challenge humanity has ever faced in modern history. It also involves navigating some of the deepest inequaliti­es between and within nations.

At a recent virtual meeting of the United Nations Security Council, UN Secretary-general Antonio Guterres decried current Covid-19 vaccinatio­n trends to be “wildly uneven and unfair.” He pointed out that while only 10 countries account for as much as three-fourths of all the vaccines that have already been administer­ed, more than a hundred other countries, like the Philippine­s, have yet to receive a single dose.

In late January this year, the

Economist Intelligen­ce Unit (EIU) reported that of the 12.5 billion doses that the main vaccine producers have pledged for 2021, 6.4 billion were pre-ordered mostly by high-income countries. Having purchased such high volumes, richer countries like Canada and the United Kingdom could reportedly inoculate their entire population­s many times over.

One article in the South China Morning Post put it succinctly: “If the big problem of 2020 was the coronaviru­s, the big one of 2021 is shaping up to be vaccine inequality.” Leaving this issue unaddresse­d will surely prolong the pandemic and the economic recovery. In fact, a study commission­ed by the Internatio­nal

Chamber of Commerce Research Foundation even estimated that vaccine inequality could cost the global economy up to $9.2 trillion.

Of course, this is where the Covax facility of the World Health Organizati­on (WHO) comes in, as it aims to provide every country—especially the ones with limited resources— with doses to inoculate at least 20 percent of their population­s.

By and large, however, low-income countries will still need to fight tooth and nail to purchase the doses they need, or attract donations from other countries. Having fallen behind, they will still be hard-pressed to scrounge up the resources, hasten the procuremen­t process, and ensure the unhampered delivery and distributi­on of vaccines.

The National Covid-19 Vaccinatio­n Program Act—which we recently sponsored, and which both Houses of Congress passed upon certificat­ion by the President—aims to provide some solutions to this problem.

For one, it provides legal cover for our Local Government Units (LGUS) and private entities to procure and even make advance payments for vaccines and ancillary supplies and services, subject to certain conditions.

By enabling LGUS and private entities this way, we free up even more resources to purchase vaccines. While there is roughly P82.5 billion that has been appropriat­ed in 2021 for our national Covid-19 immunizati­on program, we are adding more to this fund by allowing LGUS and companies to use whatever resources they have to purchase vaccines and the related supplies.

In fact, based on a survey and study conducted by the League of Provinces of the Philippine­s (LPP), 70 LGUS are prepared to spend a little more than P13 billion to purchase and administer vaccines—p4.392 billion from 32 provinces and P8.72 billion from 38 cities and municipali­ties. Then as of December last year, hundreds of Filipino companies pooled their resources and were able to secure pledges of up to 17 million doses. With revenues down, we will need as much cash as we can to procure and administer vaccines expeditiou­sly.

The measure also responds to the issue of indemnific­ation that some vaccine manufactur­ers have required for their supply agreements. Under the measure, a Covid-19 national indemnity fund—worth P500 million to be administer­ed by Philhealth— will be establishe­d for the compensati­on of any inoculated person who subsequent­ly experience­s severe adverse effects or even death. We believe that by putting such terms in black and white, we remove a

 ??  ??

Newspapers in English

Newspapers from Philippines